
STUART A. HARLIN, MD INTERVIEW: I’d rather pursue a career in racing age-group triathlons
Advisory Board member and columnist David Schmiege interviews Stuart A. Harlin, MD, for this issue. Dr. Harlin is an associate professor and the director of outpatient vascular operations within the Department of Cardiothoracic and Vascular Surgery at McGovern Medical School at The University of Texas Health Science Center at Houston.

PENUMBRA OFFERS INDIGO LIGHTNING 12 AS BASIS FOR U.S. FRANCHISE GROWTH
Penumbra Inc. has announced its next phase for vascular franchise growth with U.S. commercial availability of the Indigo System Lightning 12 and the appointments of Corey L. Teigen, MD, to chief scientific officer; and James F. Benenati, MD, FSIR, to chief medical officer – two newly created positions. Innovating the
BOSTON SCIENTIFIC STENT GAINS ADDED MEDICARE COVERAGE
Boston Scientific has been granted a new technology add-on payment (NTPA) for its Eluvia drug-eluting vascular stent system from the Centers for Medicare & Medicaid Services. Under the Inpatient Prospective Payment System (IPPS), CMS pays for a patient’s inpatient hospital stay under one bundled payment, which covers all costs for
Royal PHILIPS TO ACQUIRE INTACT VASCULAR
PHILIPS TO ACQUIRE INTACT VASCULAR Royal Philips has signed an agreement to acquire Intact Vascular Inc., a U.S.-based developer of medical devices for minimally invasive peripheral vascular procedures for $275 million upfront deferred payments when the transaction is completed. Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips’

BEING A PATIENT DURING COVID-19: Profoundly lonely, fearful, dangerous and sad
By Larry Storer I generally do not write editor columns, but the staff decided I really needed to write this one because of my perspective as a patient during the COVID-19 pandemic. My medical journey has lasted just longer than 3 months to date – 21/2 months in the hospital

READY FIRE AIM: Don’t miss your best shot waiting for the perfect time
An interview by David Schmiege, president and CEO of Vein Specialists of America with Jeffrey H. Miller, MD Dr. Miller Board-certified in Interventional Radiology and Venous and Lymphatic Medicine Diplomat of the National Board of Medical Examiners and American Board of Radiology Holds a certificate of
HOW PHYSICIANS AND SURGEONS COPE WITH COVID-19
By Robert Jennejohn Dr. Michael Y. Shao, MD is a board-certified vascular surgeon with the Swedish Medical Group. He attended the Mount Sinai School of Medicine. He has more than 17 years of experience and is currently affiliated with the Swedish Covenant Hospital in Chicago, Ill. This Interview was

PHLEBOLYMPHEDEMA: A hidden side of advanced vein disease
By Bryan Groleau COTA/L, CLT-LANA, WCC, LLE Over the last decade, oncology surgeons have succeeded in reducing the frequency and severity of oncology related lymphedema through dramatic improvements in axillary treatment. The days of vast radical mastectomies are gone. For years surgeons have been removing fewer lymph

TREATING LYMPHEDEMA: Working with a lymphedema therapist can improve patient outcomes
By Robyn “Redd” Smith, M.ED., COTA/L, CLWT, CLT, LASH-FKT A patient with two swollen legs walks into a vein clinic. Now, that may sound like the beginning of a joke, but it is actually the opening line to our story. A story showing how making an addition to your options
GROWING LYMPHEDEMA IN YOUR PRACTICE
By Manu Aggarwal, MD It has been almost three years since we added lymphedema therapy treatments to our vein practice at Vein Care Center Laser Specialists. In this time, we have had trained (via Norton School of Lymphedema) two certified lymphedema therapists (CLTs), both part-time and both originally occupational therapists.